{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:05:57Z","timestamp":1795089957492,"version":"4.10.2"},"reference-count":122,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,27]]},"DOI":"10.1093\/neuonc\/nox166","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T20:18:11Z","timestamp":1510604291000},"page":"445-456","source":"Crossref","is-referenced-by-count":277,"title":["EANO guidelines for the diagnosis and treatment of ependymal tumors"],"prefix":"10.1093","volume":"20","author":[{"given":"Roberta","family":"Rud\u00e0","sequence":"first","affiliation":[{"name":"Department of Neuro-Oncology, University of Turin and City of Health and Science University Hospital, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Reifenberger","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Medical Faculty, Heinrich Heine University D\u00fcsseldorf and German Cancer Consortium (DKTK), partner site Essen\/D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Frappaz","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Neuro-Oncologie, Centre L\u00e9on-B\u00e9rard, Institut d\u2019H\u00e9matologie et Oncologie P\u00e9diatrique et Adulte, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M","family":"Pfister","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neuro-oncology, German Cancer Research Center, DKTK, Heidelberg, Germany and Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Santarius","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg Christian","family":"Tonn","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Ludwig-Maximilians-Universit\u00e4t and DKTK partner site, University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, University of Turin and City of Health and Science University Hospital, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Cohen-Jonathan","family":"Moyal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"key":"key\n\t\t\t\t20180420105454_CIT0001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/B978-0-12-802997-8.00025-6","article-title":"Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options","volume":"134","author":"Dorfer","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"key\n\t\t\t\t20180420105454_CIT0002","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2009\u20132013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"issue":"6","key":"key\n\t\t\t\t20180420105454_CIT0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0004","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-012-0941-4","article-title":"A prognostic gene expression signature in infratentorial ependymoma","volume":"123","author":"Wani","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bpa.12050","article-title":"Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system","volume":"23","author":"Raghunathan","year":"2013","journal-title":"Brain Pathol"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0006","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/neuonc\/nou162","article-title":"Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients","volume":"17","author":"Vera-Bolanos","year":"2015","journal-title":"Neuro Oncol"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0008","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/neuonc\/now016","article-title":"Biology and management of ependymomas","volume":"18","author":"Wu","year":"2016","journal-title":"Neuro Oncol"},{"issue":"9","key":"key\n\t\t\t\t20180420105454_CIT0009","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1468-1331.2004.00867.x","article-title":"Guidance for the preparation of neurological management guidelines by EFNS scientific task forces\u2014revised recommendations 2004","volume":"11","author":"Brainin","year":"2004","journal-title":"Eur J Neurol"},{"issue":"6","key":"key\n\t\t\t\t20180420105454_CIT0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/WCO.0b013e328317efe8","article-title":"Ependymomas of the adult: molecular biology and treatment","volume":"21","author":"Rud\u00e0","year":"2008","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0011","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/cncr.30355","article-title":"Clinical presentation and outcomes for adult ependymoma patients","volume":"123","author":"Acquaye","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"key\n\t\t\t\t20180420105454_CIT0012","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/neuonc\/noq009","article-title":"Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience","volume":"12","author":"Armstrong","year":"2010","journal-title":"Neuro Oncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00431-007-0453-8","article-title":"Torticollis is a usual symptom in posterior fossa tumors","volume":"167","author":"Extremera","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3171\/2010.3.SPINE09430","article-title":"Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina","volume":"13","author":"Engelhard","year":"2010","journal-title":"J Neurosurg Spine"},{"issue":"10","key":"key\n\t\t\t\t20180420105454_CIT0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00381-009-0878-7","article-title":"Imaging of ependymomas: MRI and CT","volume":"25","author":"Yuh","year":"2009","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"key\n\t\t\t\t20180420105454_CIT0016","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/neuonc\/nov063","article-title":"Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified","volume":"17","author":"Nowak","year":"2015","journal-title":"Neuro Oncol"},{"issue":"9","key":"key\n\t\t\t\t20180420105454_CIT0017","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3174\/ajnr.A2155","article-title":"Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors","volume":"31","author":"Jaremko","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1066","key":"key\n\t\t\t\t20180420105454_CIT0018","doi-asserted-by":"crossref","first-page":"20160537","DOI":"10.1259\/bjr.20160537","article-title":"Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study","volume":"89","author":"Tensaouti","year":"2016","journal-title":"Br J Radiol"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0019","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-003-0752-8","article-title":"Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas","volume":"106","author":"Hasselblatt","year":"2003","journal-title":"Acta Neuropathol"},{"issue":"7489","key":"key\n\t\t\t\t20180420105454_CIT0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-014-1264-4","article-title":"Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-\u03baB signaling pathway","volume":"127","author":"Pietsch","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"366","key":"key\n\t\t\t\t20180420105454_CIT0022","doi-asserted-by":"crossref","first-page":"366ra161","DOI":"10.1126\/scitranslmed.aah6904","article-title":"Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas","volume":"8","author":"Bayliss","year":"2016","journal-title":"Sci Transl Med"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180420105454_CIT0024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","article-title":"Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts","volume":"10","author":"Ellison","year":"2011","journal-title":"J Negat Results Biomed"},{"issue":"19","key":"key\n\t\t\t\t20180420105454_CIT0025","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2009.27.3359","article-title":"Molecular staging of intracranial ependymoma in children and adults","volume":"28","author":"Korshunov","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0026","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-012-0981-9","article-title":"Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas","volume":"124","author":"Godfraind","year":"2012","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180420105454_CIT0027","first-page":"35","article-title":"Clinical and molecular subgroups of ependymoma in adulthood: an analysis of the German Glioma Network","author":"Gramatzki","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"key\n\t\t\t\t20180420105454_CIT0028","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.20074","article-title":"A multicenter study of the prognosis and treatment of adult brain ependymal tumors","volume":"100","author":"Reni","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0029","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3171\/jns.2005.102.4.0629","article-title":"Is gross-total resection sufficient treatment for posterior fossa ependymomas","volume":"102","author":"Rogers","year":"2005","journal-title":"J Neurosurg"},{"issue":"Pt 5","key":"key\n\t\t\t\t20180420105454_CIT0030","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/brain\/awm046","article-title":"Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients","volume":"130","author":"Metellus","year":"2007","journal-title":"Brain"},{"issue":"9","key":"key\n\t\t\t\t20180420105454_CIT0031","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/neuonc\/noq047","article-title":"Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients","volume":"12","author":"Metellus","year":"2010","journal-title":"Neuro Oncol"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0032","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3171\/2008.9.JNS08117","article-title":"Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study","volume":"110","author":"McGuire","year":"2009","journal-title":"J Neurosurg"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0033","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3171\/2015.7.JNS151187","article-title":"Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors","volume":"125","author":"Hollon","year":"2016","journal-title":"J Neurosurg"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0090-3019(00)00272-X","article-title":"Combined treatment of fourth ventricle ependymomas: report of 26 cases","volume":"54","author":"Spagnoli","year":"2000","journal-title":"Surg Neurol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1014442106111","article-title":"Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure","volume":"56","author":"Oya","year":"2002","journal-title":"J Neurooncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0036","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijrobp.2004.06.002","article-title":"Postoperative radiation therapy for grade II and III intracranial ependymoma","volume":"61","author":"Mansur","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0037","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-013-1254-8","article-title":"Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis","volume":"115","author":"Ghia","year":"2013","journal-title":"J Neurooncol"},{"key":"key\n\t\t\t\t20180420105454_CIT0038","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jocn.2015.11.014","article-title":"Treatment and survival of supratentorial and posterior fossa ependymomas in adults","volume":"28","author":"Nu\u00f1o","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0039","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3171\/2014.9.JNS14155","article-title":"Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma","volume":"122","author":"Bi","year":"2015","journal-title":"J Neurosurg"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000339320","article-title":"Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007","volume":"39","author":"Amirian","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0041","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-011-0671-9","article-title":"Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy","volume":"106","author":"Pejavar","year":"2012","journal-title":"J Neurooncol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0042","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3171\/2013.6.PEDS12535","article-title":"Long-term quality of life in children treated for posterior fossa brain tumors","volume":"12","author":"Kulkarni","year":"2013","journal-title":"J Neurosurg Pediatr"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0043","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0360-3016(99)00414-9","article-title":"Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88\/89 and HIT 91","volume":"46","author":"Timmermann","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0044","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2003.08.030","article-title":"Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study","volume":"58","author":"Massimino","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(08)70342-5","article-title":"Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study","volume":"10","author":"Merchant","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0046","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3171\/jns.2001.94.1.0027","article-title":"Surveillance neuroimaging in childhood intracranial ependymoma: how effective, how often, and for how long","volume":"94","author":"Good","year":"2001","journal-title":"J Neurosurg"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0047","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3171\/2011.6.PEDS1142","article-title":"Second-look surgery for ependymoma: the Italian experience","volume":"8","author":"Massimino","year":"2011","journal-title":"J Neurosurg Pediatr"},{"issue":"11","key":"key\n\t\t\t\t20180420105454_CIT0048","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00381-016-3225-9","article-title":"Assessing \u2018second-look\u2019 tumour resectability in childhood posterior fossa ependymoma-a centralised review panel and staging tool for future studies","volume":"32","author":"Millward","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0049","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11060-011-0624-3","article-title":"Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma","volume":"105","author":"Koshy","year":"2011","journal-title":"J Neurooncol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2016.12.025","article-title":"Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma","volume":"122","author":"Tensaouti","year":"2017","journal-title":"Radiother Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0051","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0167-8140(97)01926-9","article-title":"Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma","volume":"43","author":"Aggarwal","year":"1997","journal-title":"Radiother Oncol"},{"issue":"10","key":"key\n\t\t\t\t20180420105454_CIT0052","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/neuonc\/now108","article-title":"Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma","volume":"18","author":"Massimino","year":"2016","journal-title":"Neuro Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0053","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ijrobp.2008.09.051","article-title":"Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy","volume":"74","author":"Conter","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0054","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.ijrobp.2005.05.028","article-title":"Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma","volume":"63","author":"Merchant","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijrobp.2015.10.025","article-title":"Proton therapy in children: a systematic review of clinical effectiveness in 15 pediatric cancers","volume":"95","author":"Leroy","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"key\n\t\t\t\t20180420105454_CIT0056","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/neuonc\/not121","article-title":"Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients","volume":"15","author":"Macdonald","year":"2013","journal-title":"Neuro Oncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0057","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijrobp.2016.09.042","article-title":"Proton treatment techniques for posterior fossa tumors: consequences for linear energy transfer and dose-volume parameters for the brainstem and organs at risk","volume":"97","author":"Giantsoudi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0058","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2015.06.012","article-title":"Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors","volume":"93","author":"Pulsifer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"key\n\t\t\t\t20180420105454_CIT0059","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/0284186X.2014.957414","article-title":"Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy","volume":"53","author":"Indelicato","year":"2014","journal-title":"Acta Oncol"},{"issue":"8","key":"key\n\t\t\t\t20180420105454_CIT0060","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3174\/ajnr.A4333","article-title":"Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy","volume":"36","author":"Kralik","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"key\n\t\t\t\t20180420105454_CIT0061","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26654","article-title":"Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas","author":"Indelicato","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0062","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2015.05.018","article-title":"Imaging changes in pediatric intracranial ependymoma patients treated with proton beam radiation therapy compared to intensity modulated radiation therapy","volume":"93","author":"Gunther","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0063","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijrobp.2016.08.001","article-title":"Humbling advances in technology: protons, brainstem necrosis, and the self-driving car","volume":"97","author":"MacDonald","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180420105454_CIT0064","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2016.10.013","article-title":"Current therapy and the evolving molecular landscape of paediatric ependymoma","volume":"70","author":"Khatua","year":"2017","journal-title":"Eur J Cancer"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0065","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2001.19.5.1288","article-title":"Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology","volume":"19","author":"Grill","year":"2001","journal-title":"J Clin Oncol"},{"issue":"8","key":"key\n\t\t\t\t20180420105454_CIT0066","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1470-2045(07)70208-5","article-title":"Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG\/SIOP prospective study","volume":"8","author":"Grundy","year":"2007","journal-title":"Lancet Oncol"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0067","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/pbc.24274","article-title":"Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children\u2019s Cancer Group protocol 9942: a report from the Children\u2019s Oncology Group","volume":"59","author":"Garvin","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0068","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11060-013-1111-9","article-title":"Outcome of infants and young children with newly diagnosed ependymoma treated on the \u201cHead Start\u201d III prospective clinical trial","volume":"113","author":"Venkatramani","year":"2013","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0069","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2007.09.037","article-title":"A retrospective study of surgery and reirradiation for recurrent ependymoma","volume":"71","author":"Merchant","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00381-009-1067-4","article-title":"Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis","volume":"26","author":"Zacharoulis","year":"2010","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0071","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ijrobp.2011.10.039","article-title":"Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation","volume":"83","author":"Bouffet","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0072","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pbc.21982","article-title":"Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children","volume":"52","author":"Liu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0073","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3171\/2010.8.PEDS10252","article-title":"Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas","volume":"6","author":"Kano","year":"2010","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0074","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11060-013-1259-3","article-title":"Fractionated stereotactic radiosurgery for recurrent ependymoma in children","volume":"116","author":"Hoffman","year":"2014","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s40064-016-2562-1","article-title":"Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey","volume":"5","author":"Lob\u00f3n","year":"2016","journal-title":"Springerplus"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0076","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pbc.25831","article-title":"Radiosurgery for pediatric brain tumors","volume":"63","author":"Murphy","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0077","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2015.07.023","article-title":"Use of proton therapy for re-irradiation in pediatric intracranial ependymoma","volume":"116","author":"Eaton","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0078","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11910-010-0109-3","article-title":"Ependymomas in adults","volume":"10","author":"Gilbert","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"key\n\t\t\t\t20180420105454_CIT0079","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.clon.2013.07.009","article-title":"An overview of the management of adult ependymomas with emphasis on relapsed disease","volume":"25","author":"Iqbal","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.coc.0000158891.09531.11","article-title":"A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy","volume":"29","author":"Rehman","year":"2006","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0081","first-page":"1023","article-title":"Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma","volume":"31","author":"Freyschlag","year":"2011","journal-title":"Anticancer Res"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0082","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11060-010-0249-y","article-title":"Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review","volume":"101","author":"Kim","year":"2011","journal-title":"J Neurooncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0083","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/02688697.2012.741740","article-title":"Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report","volume":"27","author":"Khoo","year":"2013","journal-title":"Br J Neurosurg"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0084","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000355662","article-title":"Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma","volume":"59","author":"Lombardi","year":"2013","journal-title":"Chemotherapy"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/neuonc\/nov167","article-title":"Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study","volume":"18","author":"Rud\u00e0","year":"2016","journal-title":"Neuro Oncol"},{"issue":"20","key":"key\n\t\t\t\t20180420105454_CIT0086","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1002\/cncr.24524","article-title":"Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma","volume":"115","author":"Chamberlain","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0087","first-page":"AT-23","article-title":"A Phase II Study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: a CERN clinical trial [Abstract]","volume":"16","author":"Gilbert","year":"2014","journal-title":"Neuro Oncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0088","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/joc.2008.20.2.263","article-title":"O6-methylguanine-DNA-methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry","volume":"20","author":"Buccoliero","year":"2008","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20180420105454_CIT0089","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12885-016-2323-0","article-title":"Chemotherapy for intracranial ependymoma in adults","volume":"16","author":"Gramatzki","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006394407245","article-title":"Chemotherapy for advanced CNS ependymoma","volume":"45","author":"Gornet","year":"1999","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0091","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cncr.21110","article-title":"A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia","volume":"104","author":"Brandes","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0092","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/01.WNL.0000082384.15848.FA","article-title":"Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin","volume":"61","author":"Rojas-Marcos","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180420105454_CIT0093","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/jco.2009.27.15_suppl.2060","article-title":"Bevacizumab for recurrent ependymoma","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20180420105454_CIT0094","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s003810050544","article-title":"Chemotherapy for intracranial ependymomas","volume":"15","author":"Bouffet","year":"1999","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1017109414966","article-title":"High dose chemotherapy for childhood ependymona","volume":"40","author":"Grill","year":"1998","journal-title":"J Neurooncol"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0096","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pbc.24794","article-title":"A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer","volume":"61","author":"Robison","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0097","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-016-2155-4","article-title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","volume":"129","author":"Jakacki","year":"2016","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0098","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/pbc.25696","article-title":"Temozolomide treatment for pediatric refractory anaplastic ependymoma with low MGMT protein expression","volume":"63","author":"Komori","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"key\n\t\t\t\t20180420105454_CIT0099","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2009.26.8789","article-title":"Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study","volume":"28","author":"Gururangan","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11060-015-1764-7","article-title":"An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a Collaborative Ependymoma Research Network study (CERN)","volume":"123","author":"DeWire","year":"2015","journal-title":"J Neurooncol"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0101","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/cam4.713","article-title":"Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a Children\u2019s Oncology Group study ACNS1021","volume":"5","author":"Wetmore","year":"2016","journal-title":"Cancer Med"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0102","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2015.5.FOCUS15158","article-title":"Intramedullary spinal cord tumors: a review of current and future treatment strategies","volume":"39","author":"Tobin","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0103","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00701-009-0577-x","article-title":"Intramedullary low grade astrocytoma and ependymoma. Surgical results and predicting factors for clinical outcome","volume":"152","author":"Eroes","year":"2010","journal-title":"Acta Neurochir (Wien)"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0104","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1179\/1743132815Y.0000000041","article-title":"Predictors of survival in patients with spinal ependymoma","volume":"37","author":"Lin","year":"2015","journal-title":"Neurol Res"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/neuonc\/nos286","article-title":"Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas","volume":"15","author":"Oh","year":"2013","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0360-3016(86)90345-7","article-title":"Radiotherapeutic management of adult intraspinal ependymomas","volume":"12","author":"Shaw","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"key\n\t\t\t\t20180420105454_CIT0107","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.58.8.1310","article-title":"Etoposide for recurrent spinal cord ependymoma","volume":"58","author":"Chamberlain","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0108","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/2016.8.SPINE16589","article-title":"The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2","volume":"26","author":"Morris","year":"2017","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0109","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/neuonc\/nou293","article-title":"Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network","volume":"17","author":"Weber","year":"2015","journal-title":"Neuro Oncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0110","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2015.5.FOCUS15164","article-title":"Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity","volume":"39","author":"Abdulaziz","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0111","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-016-2167-0","article-title":"Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes","volume":"129","author":"Bates","year":"2016","journal-title":"J Neurooncol"},{"issue":"5","key":"key\n\t\t\t\t20180420105454_CIT0112","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0360-3016(98)00350-2","article-title":"The results of radiotherapy for ependymomas: the Mayo Clinic experience","volume":"42","author":"Schild","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"key\n\t\t\t\t20180420105454_CIT0113","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0360-3016(02)02776-1","article-title":"In regard to the radiotherapy of myxopapillary ependymomas","volume":"53","author":"Schild","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0114","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-006-9169-2","article-title":"Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center","volume":"80","author":"Akyurek","year":"2006","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-015-1955-2","article-title":"Myxopapillary ependymomas in children: imaging, treatment and outcomes","volume":"126","author":"Bandopadhayay","year":"2016","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-016-2218-6","article-title":"Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database","volume":"130","author":"Lucchesi","year":"2016","journal-title":"J Neurooncol"},{"issue":"2","key":"key\n\t\t\t\t20180420105454_CIT0117","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijrobp.2012.05.001","article-title":"Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation","volume":"85","author":"Agbahiwe","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"key\n\t\t\t\t20180420105454_CIT0118","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/pbc.22614","article-title":"Adjuvant radiotherapy in the treatment of pediatric myxopapillary ependymomas","volume":"55","author":"Al-Halabi","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"key\n\t\t\t\t20180420105454_CIT0119","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1200\/JCO.2015.65.7825","article-title":"Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis","volume":"34","author":"Ramaswamy","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180420105454_CIT0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","article-title":"The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants","volume":"133","author":"Pajtler","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"7 Pt 1","key":"key\n\t\t\t\t20180420105454_CIT0121","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1078-0432.CCR-05-2363","article-title":"Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma","volume":"12","author":"Mendrzyk","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20180420105454_CIT0122","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/1078-0432.CCR-11-2489","article-title":"Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children\u2019s Cancer Leukaemia Group (CCLG), Societe Francaise d\u2019Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP)","volume":"18","author":"Kilday","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/20\/4\/445\/24688019\/nox166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:40:21Z","timestamp":1603309221000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/20\/4\/445\/4673200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,29]]},"references-count":122,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,11,29]]},"published-print":{"date-parts":[[2018,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nox166","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2017,11,29]]}}}